Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UroPath is a specialized urological pathology laboratory that provides comprehensive diagnostic services to urologists and their patients. The company focuses on the accurate diagnosis and management of urological conditions, including prostate, bladder, and kidney cancers, through advanced histopathology and molecular testing. Originally an independent entity, UroPath was acquired by Poplar Healthcare in 2011 to serve as its dedicated urology division. Today, it operates as a leading provider of subspecialized pathology services, utilizing state-of-the-art technology to deliver precise results that guide clinical decision-making. Its service model is designed to integrate seamlessly with urology practices, offering expert consultation and rapid turnaround times.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroPath.